Peptides and compounds that bind to thrombopoietin receptors

Details for Australian Patent Application No. 2004270656 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Weis, Jeffery Kenneth; MacDonald, Brian R.; Yurkow, Edward John

Agent Shelston IP

Pub. Number AU-B-2004270656

PCT Pub. Number WO2005/023834

Priority 60/498,740 28.08.03 US

Filing date 13 August 2004

Wipo publication date 17 March 2005

Acceptance publication date 10 March 2011

International Classifications

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023834 Priority application(s): WO2005/023834

10 March 2011 Application Accepted

  Published as AU-B-2004270656

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270660-Flame retardants with high halogen content and low viscosity

2004270655-Methods for inhibiting tumor cell proliferation